ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1151

Colonic Organoids to Study the Role of HLA-B27 in Gastrointestinal Epithelial Biology

Alec Furst1, John Davis1, Manuel Rodriguez1, Kimberly Ogle1, James T. Rosenbaum2 and Tejpal Gill1, 1OHSU, Portland, OR, 2Legacy Devers Eye Institute, Portland, OR

Meeting: ACR Convergence 2022

Keywords: Animal Model, Ankylosing spondylitis (AS), Inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Axial spondyloarthritis (axSpA) is defined clinically as inflammatory back pain along with peripheral arthritis, and extra-articular manifestations involving the eye, gut, and skin. Even though the exact mechanisms underlying HLA-B27 associated axSpA and disease susceptibility are unknown, several observations including microscopic gut lesions, clinical overlap with Crohn’s disease, and microbial dysbiosis point to the gut as a potential primary cause. However, the role of HLA-B27 associated alteration in gut epithelial biology or host-microbe interaction is not clear in axSpA pathogenesis. Therefore, we have developed colonic organoids from HLA-B27 positive and negative healthy individuals, axSpA and IBD patients, as well as HLA-B27 transgenic (Tg) and wild-type (Wt) rats to study the effect of HLA-B27 on host-microbe interactions and epithelial cell biology.

Methods: To generate human colonic organoids, frozen biopsies from healthy individuals undergoing elective colonoscopies, and axSpA and IBD patients undergoing scheduled colonoscopies were used. These biopsies were minced and the tissue was digested on a shaker to release the crypts. The crypts were washed and resuspended in undiluted Cultrex reduced-growth-factor basement membrane extract. The organoids were expanded after 4-7 days by mechanical disruption and splitting. Rat organoids from HLA-B27 Tg and Wt animals were generated from colon tissue using a method similar to human organoid generation with sight modifications. The organoids were stained with antibodies for various epithelial markers for cell differentiation (Ki67), tight junction proteins (Occludin, Claudin-4,) and goblet cells (Muc2) and compared among healthy individuals with and without HLA-B27, HLA-B27 positive axSpA patients, and IBD patients.

Results: We developed colonic organoids from multiple HLA-B27 positive and negative individuals (Figure 1) and demonstrated that organoids maintain their stemness and ability to differentiate into mature (lobular) organoids and epithelial monolayers. Immunofluorescence studies revealed a decreased mucin production in goblet cells (Muc2), while we did not observe any changes in cell proliferation (Ki67) or tight junction proteins (Occludin, Claudin-4) in HLA-B27 positive healthy individuals, as well as axSpA and IBD patients in comparison with the HLA-B27 negative healthy individuals. Since our sample numbers are low (N=1-3/group), we are confirming these results on more organoid samples. Immunohistochemistry analysis has also shown less mucin production in the goblet cells from the colon of HLA-B27 Tg rats. To determine host-microbe interactions at the epithelial surface, we are characterizing gene dysregulation in endotoxin-treated colonic organoids using RNA-seq analysis.

Conclusion: The preliminary results reveal decreased mucus production in HLA-B27 positive healthy individuals and patients with axSpA and IBD. Furthermore, mechanistic studies to determine the effect of HLA-B27 on decreased mucus production are underway.

Supporting image 1

Representative images from HLA-B27 negative healthy control (HC), HLA-B27 positive HC, HLA-B27 positive axSpA, and HLA-B27 negative IBD patient colonic organoid lines. Organoids are shown after the establishment of cultures (day 4), at 4x (top panel) or 10x (bottom panel). The arrows are pointing to spheroids or early-stage organoids.


Disclosures: A. Furst, None; J. Davis, None; M. Rodriguez, None; K. Ogle, None; J. Rosenbaum, Abbvie, Gilead, Novartis, Horizon Therapeutics, Eli Lilly, Celgene, Pfizer, UpToDate, Revolo, Priovant, Corvus, Affibody; T. Gill, None.

To cite this abstract in AMA style:

Furst A, Davis J, Rodriguez M, Ogle K, Rosenbaum J, Gill T. Colonic Organoids to Study the Role of HLA-B27 in Gastrointestinal Epithelial Biology [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/colonic-organoids-to-study-the-role-of-hla-b27-in-gastrointestinal-epithelial-biology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/colonic-organoids-to-study-the-role-of-hla-b27-in-gastrointestinal-epithelial-biology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology